Jeong James Lee - 16 Jul 2024 Form 3 Insider Report for ChromaDex Corp. (NAGE)

Role
Interim CFO
Signature
/s/ Jeong James Lee
Issuer symbol
NAGE
Transactions as of
16 Jul 2024
Net transactions value
$0
Form type
3
Filing time
26 Jul 2024, 16:52:56 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 8,334 $3.66 Direct F1
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 17,000 $4.04 Direct F2
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 50,000 $3.97 Direct F3
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 32,386 $3.84 Direct F4
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 30,800 $3.27 Direct F5
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 11,000 $11.83 Direct F6
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 42,219 $2.67 Direct F7
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 58,097 $1.82 Direct F8
holding CDXC Employee Stock Options (right to buy) 16 Jul 2024 Common Stock 82,734 $1.52 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vested on July 6, 2016 and the remaining shares subject to the option have vested in a series of 36 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F2 One-fourth of the shares subject to the option vested on July 14, 2017 and the remaining shares subject to the option have vested in a series of 36 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F3 One-third of the shares subject to the option vested on September 29, 2018 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F4 One-third of the shares subject to the option vested on February 21, 2020 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F5 One-third of the shares subject to the option vested on February 25, 2021 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F6 One-third of the shares subject to the option vested on March 15, 2022 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of July 16, 2024.
F7 One-third of the shares subject to the option vested on February 17, 2023 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.
F8 One-third of the shares subject to the option vested on February 15, 2024 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.
F9 One-third of the shares subject to the option shall vest on February 22, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter.